In our laboratory at Biocant Park in Cantanhede, Portugal our Colleagues Artur Rodrigues and Vanessa F. work on CHO4Tx®, our brand-new high performance CHO 🧪 transfection system.
🧐 Is your objective to improve efficiency in the rapid production of protein candidates for R&D in therapeutics or diagnostics?
👉 We at Magellan Biologics & Consulting proudly support the scientificcommunity in their R&D projects through our CHO4Tx® product portfolio that allows in-house, fast, easy and efficient transient proteinexpression in CHO cells and through personalized advices and consultancies.
New Peer-Reviewed Paper in Antibodies Highlights Pfizer’s Outstanding Results with CHO 4Tx®
At the heart of this publication, entitled “A Robust, High-Titer, Semi-Automated, and In-Culture Antibody-Capturing Transient CHO Platform Technology” and co-authored by Pfizer, Magellan Biologics, and
7 November 2025
